Safety and Efficacy of Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.11.097
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2015
Authors
Publisher
Elsevier BV